GENEVA, July 27 -- ELI LILLY AND COMPANY filed a patent application (US2026/011289) for “SMALL MOLECULE ALPHA4BETA7 INTEGRIN INHIBITOR FOR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE”. With publication no. WO/2026/156089, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4418
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....